Recent studies into retatrutide, a dual stimulant for GLP-1 and GIP receptors, are showing significant results in managing weight gain and diabetes 2 disease. Preclinical information suggest a unique mechanism https://shopretatrutidepeptide.com/2026/03/12/what-is-retatrutide-peptide/